Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence

BACKGROUND: SARS‐CoV‐2 infection triggers different auto‐antibodies, including anti‐apolipoprotein A‐1 IgGs (AAA1), which could be of concern as mediators of persistent symptoms. We determined the kinetics of AAA1 response over after COVID‐19 and the impact of AAA1 on the inflammatory response and s...

Descripción completa

Detalles Bibliográficos
Autores principales: L’Huillier, Arnaud G., Pagano, Sabrina, Baggio, Stephanie, Meyer, Benjamin, Andrey, Diego O., Nehme, Mayssam, Guessous, Idris, Eberhardt, Christiane S., Huttner, Angela, Posfay‐Barbe, Klara M., Yerly, Sabine, Siegrist, Claire‐Anne, Kaiser, Laurent, Vuilleumier, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348059/
https://www.ncbi.nlm.nih.gov/pubmed/35598178
http://dx.doi.org/10.1111/eci.13818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348059/
https://www.ncbi.nlm.nih.gov/pubmed/35598178
http://dx.doi.org/10.1111/eci.13818

Ejemplares similares